USP19
Basic information
Region (hg38): 3:49108046-49120938
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the USP19 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 81 | 88 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 2 | 2 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 81 | 9 | 1 |
Variants in USP19
This is a list of pathogenic ClinVar variants found in the USP19 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-49108968-C-T | not specified | Uncertain significance (Aug 14, 2024) | ||
3-49109005-C-T | not specified | Uncertain significance (Mar 02, 2023) | ||
3-49109010-G-C | not specified | Uncertain significance (Feb 22, 2023) | ||
3-49109046-C-T | not specified | Uncertain significance (Jun 28, 2023) | ||
3-49109071-T-A | not specified | Uncertain significance (Sep 01, 2021) | ||
3-49109119-C-T | not specified | Uncertain significance (Jun 21, 2023) | ||
3-49109127-C-T | not specified | Uncertain significance (Jun 02, 2023) | ||
3-49109135-C-T | Likely benign (Oct 24, 2018) | |||
3-49110192-C-T | not specified | Uncertain significance (Nov 10, 2024) | ||
3-49110222-G-A | not specified | Uncertain significance (Apr 20, 2023) | ||
3-49110273-G-A | not specified | Uncertain significance (Feb 28, 2023) | ||
3-49110321-C-T | not specified | Uncertain significance (Nov 09, 2024) | ||
3-49110329-G-A | not specified | Uncertain significance (Sep 04, 2024) | ||
3-49110452-C-G | not specified | Uncertain significance (Jul 06, 2024) | ||
3-49110561-G-T | not specified | Uncertain significance (Aug 10, 2023) | ||
3-49110703-C-A | Benign (Oct 24, 2018) | |||
3-49110781-G-A | not specified | Uncertain significance (Aug 09, 2021) | ||
3-49110846-T-C | not specified | Uncertain significance (Apr 07, 2023) | ||
3-49111001-T-A | not specified | Uncertain significance (Apr 17, 2024) | ||
3-49111008-G-C | not specified | Uncertain significance (Mar 20, 2023) | ||
3-49111025-C-T | not specified | Uncertain significance (Jul 26, 2022) | ||
3-49111038-C-T | not specified | Uncertain significance (Jan 06, 2023) | ||
3-49111103-C-T | not specified | Uncertain significance (Oct 19, 2024) | ||
3-49111146-C-A | not specified | Uncertain significance (Oct 02, 2023) | ||
3-49111148-A-G | not specified | Uncertain significance (Oct 28, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
USP19 | protein_coding | protein_coding | ENST00000434032 | 26 | 12893 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.00000526 | 124790 | 0 | 12 | 124802 | 0.0000481 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.99 | 691 | 855 | 0.808 | 0.0000532 | 9131 |
Missense in Polyphen | 219 | 331.42 | 0.66078 | 3515 | ||
Synonymous | 1.63 | 298 | 336 | 0.887 | 0.0000198 | 2966 |
Loss of Function | 6.66 | 7 | 64.9 | 0.108 | 0.00000332 | 733 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000163 | 0.000161 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000556 | 0.0000556 |
Finnish | 0.0000464 | 0.0000464 |
European (Non-Finnish) | 0.0000378 | 0.0000353 |
Middle Eastern | 0.0000556 | 0.0000556 |
South Asian | 0.0000654 | 0.0000654 |
Other | 0.000167 | 0.000165 |
dbNSFP
Source:
- Function
- FUNCTION: Deubiquitinating enzyme that regulates the degradation of various proteins. Deubiquitinates and prevents proteasomal degradation of RNF123 which in turn stimulates CDKN1B ubiquitin- dependent degradation thereby playing a role in cell proliferation. Involved in decreased protein synthesis in atrophying skeletal muscle. Modulates transcription of major myofibrillar proteins. Also involved in turnover of endoplasmic- reticulum-associated degradation (ERAD) substrates. Regulates the stability of BIRC2/c-IAP1 and BIRC3/c-IAP2 by preventing their ubiquitination. Required for cells to mount an appropriate response to hypoxia and rescues HIF1A from degradation in a non- catalytic manner. Plays an important role in 17 beta-estradiol (E2)-inhibited myogenesis. Decreases the levels of ubiquitinated proteins during skeletal muscle formation and acts to repress myogenesis. Exhibits a preference towards 'Lys-63'-linked ubiquitin chains. {ECO:0000269|PubMed:19465887, ECO:0000269|PubMed:21849505, ECO:0000269|PubMed:22128162, ECO:0000269|PubMed:22689415}.;
- Pathway
- Post-translational protein modification;Metabolism of proteins;Ub-specific processing proteases;Deubiquitination
(Consensus)
Intolerance Scores
- loftool
- 0.318
- rvis_EVS
- -1.59
- rvis_percentile_EVS
- 3.11
Haploinsufficiency Scores
- pHI
- 0.174
- hipred
- Y
- hipred_score
- 0.794
- ghis
- 0.548
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.672
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Usp19
- Phenotype
- growth/size/body region phenotype; cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; reproductive system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Zebrafish Information Network
- Gene name
- usp19
- Affected structure
- post-vent region
- Phenotype tag
- abnormal
- Phenotype quality
- curled
Gene ontology
- Biological process
- protein deubiquitination;ubiquitin-dependent ERAD pathway;regulation of protein stability;response to endoplasmic reticulum stress;negative regulation of skeletal muscle tissue development;protein stabilization;protein K48-linked deubiquitination;positive regulation of cell cycle process;regulation of cellular response to hypoxia;negative regulation of proteasomal protein catabolic process;regulation of ERAD pathway
- Cellular component
- endoplasmic reticulum membrane;cytosol;integral component of membrane
- Molecular function
- thiol-dependent ubiquitin-specific protease activity;protein binding;ubiquitin protein ligase binding;thiol-dependent ubiquitinyl hydrolase activity;metal ion binding;Hsp90 protein binding;Lys48-specific deubiquitinase activity